According to the announcement of Buchang Pharmaceutical, it was learned on July 16 that the controlling shareholder, Buchang, had pledged 29 million shares, accounting for 2.75% of the company's total share capital. The pledger was Chiyu Bank Co., Ltd. for operating needs. As of the disclosure date of the announcement, Bu Chang had pledged 102 million shares, accounting for 20.68% of the total number of shares in the company and 9.63% of the company's total share capital. Together, Bu Chang and his co-actors held 56.72% of the company's total share capital, and their cumulative pledged shares accounted for 16.97% of the total number of company shares they held, accounting for 9.63% of the company's total share capital. This pledge will not lead to a change in actual control and will not affect the company's production, operation and governance.

According to the announcement of Buchang Pharmaceutical, it was learned on July 16 that the controlling shareholder, Buchang, had pledged 29 million shares, accounting for 2.75% of the company's total share capital. The pledger was Chiyu Bank Co., Ltd. for operating needs. As of the disclosure date of the announcement, Bu Chang had pledged 102 million shares, accounting for 20.68% of the total number of shares in the company and 9.63% of the company's total share capital. Together, Bu Chang and his co-actors held 56.72% of the company's total share capital, and their cumulative pledged shares accounted for 16.97% of the total number of company shares they held, accounting for 9.63% of the company's total share capital. This pledge will not lead to a change in actual control and will not affect the company's production, operation and governance.